Arvanitakis, Z., Shah, R. C., & Bennett, D. A. (2019). Diagnosis and management of dementia: Review. JAMA, 322(16), 1589–1599. https://doi.org/10.1001/jama.2019.4782

Article  PubMed  PubMed Central  Google Scholar 

Ayodele, T., Rogaeva, E., Kurup, J. T., Beecham, G., & Reitz, C. (2021). Early-onset Alzheimer’s disease: What is missing in research? Current Neurology and Neuroscience Reports, 21(2), 4. https://doi.org/10.1007/s11910-020-01090-y

Article  PubMed  PubMed Central  Google Scholar 

Bagyinszky, E., Kang, M. J., Van Giau, V., Shim, K., Pyun, J. M., Suh, J., An, S. S. A., & Kim, S. (2019). Novel amyloid precursor protein mutation, Val669Leu (“Seoul APP”), in a Korean patient with early-onset Alzheimer’s disease. Neurobiology of Aging, 84(231), 236. https://doi.org/10.1016/j.neurobiolaging.2019.08.026

Article  Google Scholar 

Ben, K. N., Tyteca, D., Marinangeli, C., Depuydt, M., Collet, J. F., Courtoy, P. J., Renauld, J. C., Constantinescu, S., Octave, J. N., & Kienlen-Campard, P. (2012). Structural features of the KPI domain control APP dimerization, trafficking, and processing. FASEB Journal, 26(2), 855–867. https://doi.org/10.1096/fj.11-190207

Article  CAS  Google Scholar 

Bolos, M., Hu, Y., Young, K. M., Foa, L., & Small, D. H. (2014). Neurogenin 2 mediates amyloid-beta precursor protein-stimulated neurogenesis. Journal of Biological Chemistry, 289(45), 31253–31261. https://doi.org/10.1074/jbc.M114.581918

Article  CAS  PubMed  PubMed Central  Google Scholar 

Chetelat, G., Arbizu, J., Barthel, H., Garibotto, V., Law, I., Morbelli, S., van de Giessen, E., Agosta, F., Barkhof, F., Brooks, D. J., Carrillo, M. C., Dubois, B., Fjell, A. M., Frisoni, G. B., Hansson, O., Herholz, K., Hutton, B. F., Jack, C. R., Lammertsma, A., & Drzezga, A. (2020). Amyloid-PET and (18)F-FDG-PET in the diagnostic investigation of Alzheimer’s disease and other dementias. Lancet Neurology, 19(11), 951–962. https://doi.org/10.1016/S1474-4422(20)30314-8

Article  CAS  PubMed  Google Scholar 

Citron, M., Oltersdorf, T., Haass, C., McConlogue, L., Hung, A. Y., Seubert, P., Vigo-Pelfrey, C., Lieberburg, I., & Selkoe, D. J. (1992). Mutation of the beta-amyloid precursor protein in familial Alzheimer’s disease increases beta-protein production. Nature, 360(6405), 672–674. https://doi.org/10.1038/360672a0

Article  ADS  CAS  PubMed  Google Scholar 

Di Fede, G., Catania, M., Morbin, M., Rossi, G., Suardi, S., Mazzoleni, G., & Tagliavini, F. (2009). A recessive mutation in the APP gene with dominant-negative effect on amyloidogenesis. Science, 323(5920), 1473–1477. https://doi.org/10.1126/science.1168979

Article  ADS  CAS  PubMed  PubMed Central  Google Scholar 

Hansson, O. (2021). Biomarkers for neurodegenerative diseases. Nature Medicine, 27(6), 954–963. https://doi.org/10.1038/s41591-021-01382-x

Article  CAS  PubMed  Google Scholar 

Hsiao, K., Chapman, P., Nilsen, S., Eckman, C., Harigaya, Y., Younkin, S., Yang, F., & Cole, G. (1996). Correlative memory deficits, Abeta elevation, and amyloid plaques in transgenic mice. Science, 274(5284), 99–102. https://doi.org/10.1126/science.274.5284.99

Article  ADS  CAS  PubMed  Google Scholar 

Jack, C. J., Bennett, D. A., Blennow, K., Carrillo, M. C., Dunn, B., Haeberlein, S. B., Holtzman, D. M., Jagust, W., Jessen, F., Karlawish, J., Liu, E., Molinuevo, J. L., Montine, T., Phelps, C., Rankin, K. P., Rowe, C. C., Scheltens, P., Siemers, E., Snyder, H. M., & Sperling, R. (2018). NIA-AA research framework: Toward a biological definition of Alzheimer’s disease. Alzheimer’s Dement., 14(4), 535–562. https://doi.org/10.1016/j.jalz.2018.02.018

Article  Google Scholar 

Jonsson, T., Atwal, J. K., Steinberg, S., Snaedal, J., Jonsson, P. V., Bjornsson, S., Stefansson, H., Sulem, P., Gudbjartsson, D., Maloney, J., Hoyte, K., Gustafson, A., Liu, Y., Lu, Y., Bhangale, T., Graham, R. R., Huttenlocher, J., Bjornsdottir, G., Andreassen, O. A., & Stefansson, K. (2012). A mutation in APP protects against Alzheimer’s disease and age-related cognitive decline. Nature, 488(7409), 96–99. https://doi.org/10.1038/nature11283

Article  ADS  CAS  PubMed  Google Scholar 

Kimura, A., Hata, S., & Suzuki, T. (2016). Alternative selection of Beta-site APP-Cleaving Enzyme 1 (BACE1) cleavage sites in Amyloid beta-Protein Precursor (APP) harboring protective and pathogenic mutations within the Abeta Sequence. Journal of Biological Chemistry, 291(46), 24041–24053. https://doi.org/10.1074/jbc.M116.744722

Article  CAS  PubMed  PubMed Central  Google Scholar 

Knopman, D. S., Amieva, H., Petersen, R. C., Chetelat, G., Holtzman, D. M., Hyman, B. T., Nixon, R. A., & Jones, D. T. (2021). Alzheimer disease. Nature Reviews Disease Primers, 7(1), 33. https://doi.org/10.1038/s41572-021-00269-y

Article  PubMed  PubMed Central  Google Scholar 

Lannfelt, L., Viitanen, M., Johanssn, K., & Axelman, K. (1993). Low frequency of the APP670671 mutation in familial Alzheimer’s disease in Sweden. Neuroscience Letters, 153(1993), 85–87.

Article  CAS  PubMed  Google Scholar 

Mahalingam, S., & Chen, M. K. (2019). Neuroimaging in dementias. Seminars in Neurology, 39(2), 188–199. https://doi.org/10.1055/s-0039-1678580

Article  PubMed  Google Scholar 

Mahaman, Y., Embaye, K. S., Huang, F., Li, L., Zhu, F., Wang, J. Z., Liu, R., Feng, J., & Wang, X. (2022). Biomarkers used in Alzheimer’s disease diagnosis, treatment, and prevention. Ageing Research Reviews, 74, 101544. https://doi.org/10.1016/j.arr.2021.101544

Article  CAS  PubMed  Google Scholar 

Mattson, M. P. (2004). Pathways towards and away from Alzheimer’s disease. Nature, 430(7000), 631–639. https://doi.org/10.1038/nature02621

Article  ADS  CAS  PubMed  PubMed Central  Google Scholar 

McKhann, G. M., Knopman, D. S., Chertkow, H., Hyman, B. T., Jack, C. J., Kawas, C. H., Klunk, W. E., Koroshetz, W. J., Manly, J. J., Mayeux, R., Mohs, R. C., Morris, J. C., Rossor, M. N., Scheltens, P., Carrillo, M. C., Thies, P., Weintraub, S., & Phelps, C. H. (2011). The diagnosis of dementia due to Alzheimer’s disease: Recommendations from the National Institute on Aging-Alzheimer’s Association workgroups on diagnostic guidelines for Alzheimer’s disease. Alzheimer’s & Dementia, 7(3), 263–269. https://doi.org/10.1016/j.jalz.2011.03.005

Article  Google Scholar 

Migliore, L., & Coppede, F. (2022). Gene-environment interactions in Alzheimer disease: The emerging role of epigenetics. Nature Reviews Neurology, 18(11), 643–660. https://doi.org/10.1038/s41582-022-00714-w

Article  CAS  PubMed  Google Scholar 

Milà-Alomà, M., Salvadó, G., Gispert, J. D., Vilor-Tejedor, N., Grau-Rivera, O., Sala-Vila, A., Sánchez-Benavides, G., Arenaza-Urquijo, E. M., Crous-Bou, M., González-de-Echávarri, J. M., Minguillon, C., Fauria, K., Simon, M., Kollmorgen, G., Zetterberg, H., Blennow, K., Suárez-Calvet, M., & Molinuevo, J. L. (2020). Amyloid beta, tau, synaptic, neurodegeneration, and glial biomarkers in the preclinical stage of the Alzheimer’s continuum. Alzheimers Dement, 16(10), 1358–1371. https://doi.org/10.1002/alz.12131

Article  PubMed  Google Scholar 

Mullan, M., Crawford, F., Axelman, K., Houlden, H., Lilius, L., Winblad, B., & Lannfelt, L. (1992). A pathogenic mutation for probable Alzheimer’s disease in the APP gene at the N-terminus of beta-amyloid. Nature Genetics, 1(5), 345–347. https://doi.org/10.1038/ng0892-345

Article  CAS  PubMed  Google Scholar 

Qin, Q., Yin, Y., Wang, Y., Lu, Y., Tang, Y., & Jia, J. (2020). Gene mutations associated with early onset familial Alzheimer’s disease in China: An overview and current status. Molecular Genetics & Genomic Medicine, 8(10), e1443. https://doi.org/10.1002/mgg3.1443

Article  CAS  Google Scholar 

Scheltens, P., De Strooper, B., Kivipelto, M., Holstege, H., Chételat, G., Teunissen, C. E., Cummings, J., & van der Flier, W. M. (2021). Alzheimer’s disease. Lancet, 397(10284), 1577–1590. https://doi.org/10.1016/S0140-6736(20)32205-4

Article  CAS  PubMed  PubMed Central  Google Scholar 

Tiwari, S., Atluri, V., Kaushik, A., Yndart, A., & Nair, M. (2019). Alzheimer’s disease: Pathogenesis, diagnostics, and therapeutics. International Journal of Nanomedicine, 14(5541), 5554. https://doi.org/10.2147/IJN.S200490

Article  Google Scholar 

Valotassiou, V., Malamitsi, J., Papatriantafyllou, J., Dardiotis, E., Tsougos, I., Psimadas, D., Alexiou, S., Hadjigeorgiou, G., & Georgoulias, P. (2018). SPECT and PET imaging in Alzheimer’s disease. Annals of Nuclear Medicine, 32(9), 583–593. https://doi.org/10.1007/s12149-018-1292-6

Article  CAS  PubMed  Google Scholar